Skip to content

Clinical Study for Tongmai Yangxin Pill in Treating Premature Atrial Contraction With Qi and Yin Deficiency Syndrome

Clinical Study for Tongmai Yangxin Pill in Treating Premature Atrial Contraction With Qi and Yin Deficiency Syndrome

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002579
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-09-06
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature atrial contraction

Interventions

Sponsors

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) In accordance with the above-mentioned diagnostic criteria for Chinese medicine, the syndrome of traditional Chinese medicine belongs to the syndrome of deficiency of Qi and Yin; 2) In line with the above-mentioned Western diagnostic criteria, there are clinical symptoms, and the 24h dynamic electrocardiogram room is greater than or equal to 720 times earlier; 3) Sign the informed consent form; 4) Aged between 18 and 75 years, male or female.

Exclusion criteria

Exclusion criteria: 1) There are clear predisposing factors, such as infection, electrolyte imbalance (hypokalemia, hypomagnesemia, hyperkalemia); 2) Those who are allergic to the drug ingredients; 3) Patients have other serious liver diseases, heart diseases, kidney diseases, and malignant tumors that affect the evaluation of this study; 4) participated in other drug research within 3 months before using the study drug; 5) Those who have been diagnosed as angina or chest pain caused by acute myocardial infarction, acute heart failure, severe neurosis, hyperthyroidism, gastroesophageal reflux disease and cervical spondylosis; 6) pregnant or lactating women; 7) Combined with severe hypertension (above blood pressure 180 / 110 mmHg), diabetic ketoacidosis, ketoacidosis and severe infection in the past 1 month; 8) The investigator believes that he cannot participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
24-hour dynamic electrocardiogram;

Secondary

MeasureTime frame
TCM symptoms;General situation;

Countries

China

Contacts

Public ContactZhao Yingqiang

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

zhaoyingqiang1000@126.com+86 13920089969

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026